Target Name: TOM complex
NCBI ID: P17822
Review Report on TOM complex Target / Biomarker Content of Review Report on TOM complex Target / Biomarker
TOM complex
Other Name(s): Mitochondrial Import Outer Membrane Translocase (TOM) Complex | Translocase of the mitochondrial outer membrane (TOM) complex

TOM Complex: A Potential Drug Target and Biomarker for Mitochondrial Import Outer Membrane Translocase (TOM)

Introduction

Mitochondria are critical organelles that play a vital role in maintaining energy metabolism and cell survival. They are also involved in the production of various signaling molecules, including pro-inflammatory cytokines and neurotransmitters, which have significant impacts on cellular processes. The Mitochondrial Import Outer Membrane Translocase (TOM) Complex is a protein complex that is essential for the proper import of mitochondrial proteins into the mitochondrial outer membrane (MOM). TOM complex has been implicated in various cellular processes, including cell growth, apoptosis, and inflammation. Therefore, it is a potential drug target and biomarker for various diseases.

The TOM Complex

TOM complex is a protein complex that consists of several subunits, including TOM1, TOM2, TOM3, and TOM4. These subunits are held together by various interactions, including ion channels, non-heme ligands, and hydrophobic interactions. TOM1, the largest subunit, is responsible for the import of pro-inflammatory cytokines, such as interleukin-1尾 (IL-1尾), onto the MOM. TOM2 and TOM3 are involved in the localization of TOM1 to the MOM, while TOM4 is involved in the assembly and disassembly of the TOM complex.

Function of TOM Complex

TOM complex is critical for the proper import of mitochondrial proteins into the MOM. The MOM is a thin layer of lipid bilayer membrane, which separates the cytoplasm from the mitochondria. It serves as a barrier that restricts the access of foreign molecules, including toxins and pathogens, to the mitochondria. TOM complex helps to overcome this barrier by creating a path for the import of mitochondrial proteins through the MOM.

In addition to its role in protein import, TOM complex is also involved in the regulation of cellular processes, including cell growth, apoptosis, and inflammation. TOM1 has been shown to play a role in cell growth by regulating the cell cycle and preventing the accumulation of cell debris. TOM2 and TOM3 have been shown to be involved in the regulation of apoptosis, which is the process by which cells undergo programmed cell death. TOM4 has been shown to be involved in the regulation of inflammation, including the production of pro- inflammatory cytokines.

Drug Targeting TOM Complex

The TOM complex is a potential drug target for various diseases. One of the primary goals of drug development is to target diseases caused by the overproduction or underproduction of specific proteins. The TOM complex has been shown to be involved in the production of pro-inflammatory cytokines, which can contribute to the development of inflammatory diseases, such as cardiovascular disease, cancer, and autoimmune disorders.

In addition to its role in inflammation, TOM complex is also involved in the regulation of cellular processes that are critical for maintaining cellular health. The regulation of cell growth, apoptosis, and the production of signaling molecules are critical for maintaining cellular homeostasis, which is critical for the survival of cells. Therefore, targeting TOM complex with drugs that can modulate its activity could be an effective way to treat various diseases.

Biomarker Assays

There are several biomarkers that can be used to assess the activity of TOM complex, including mitochondrial protein levels, the expression of pro-inflammatory cytokines, and the activity of the TOM complex itself. One of the most promising biomarkers for TOM complex is the expression of pro-inflammatory cytokines, such as IL-1尾, IL-6, and TNF-伪. The expression of these cytokines is often increased in diseases caused by the overproduction or underproduction of specific proteins, including

Protein Name: TOM Complex

The "TOM complex Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TOM complex comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

TOM1 | TOM1L1 | TOM1L2 | TOMM20 | TOMM20L | TOMM20P2 | TOMM22 | TOMM34 | TOMM40 | TOMM40L | TOMM40P2 | TOMM5 | TOMM6 | TOMM7 | TOMM70 | Tomoregulin | TONSL | TONSL-AS1 | TOP1 | TOP1MT | TOP1P1 | TOP1P2 | TOP2A | TOP2B | TOP3A | TOP3B | TOP3BP1 | TOPAZ1 | TOPBP1 | TOPORS | TOR1A | TOR1AIP1 | TOR1AIP2 | TOR1B | TOR2A | TOR3A | TOR4A | TOX | TOX2 | TOX3 | TOX4 | TP53 | TP53AIP1 | TP53BP2 | TP53I11 | TP53I13 | TP53I3 | TP53INP1 | TP53INP2 | TP53RK | TP53TG1 | TP53TG3 | TP53TG3HP | TP53TG5 | TP63 | TP73 | TP73-AS1 | TPBG | TPBGL | TPCN1 | TPCN2 | TPD52 | TPD52L1 | TPD52L2 | TPD52L3 | TPGS1 | TPGS2 | TPH1 | TPH2 | TPI1 | TPI1P1 | TPI1P2 | TPI1P3 | TPK1 | TPM1 | TPM2 | TPM3 | TPM3P5 | TPM3P7 | TPM3P9 | TPM4 | TPMT | TPO | TPP1 | TPP2 | TPPP | TPPP2 | TPPP3 | TPR | TPRA1 | TPRG1 | TPRG1-AS1 | TPRG1-AS2 | TPRG1L | TPRKB | TPRN | TPRX1 | TPRXL | TPSAB1 | TPSB2